MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cells

Por Liu, Lucy, Gaboriaud, Nicolas, Vougogianopoulou, Konstantina, Tian, Yan, Wu, Jun, Wen, Wei, Skaltsounis, Leandros, Jove, Richard
Publicado em 2014

A novel 7-bromoindirubin with potent anticancer activity suppresses survival of human melanoma cells associated with inhibition of STAT3 and Akt signaling

Por Liu, Lucy, Kritsanida, Marina, Magiatis, Prokopios, Gaboriaud, Nicolas, Wang, Yan, Wu, Jun, Buettner, Ralf, Yang, Fan, Nam, Sangkil, Skaltsounis, Leandros, Jove, Richard
Publicado em 2012